Celldex to Report Fourth Quarter and Year-End 2015 Business/Financial Results and Host 2016 Corporate Strategy Conference Cal...
February 18 2016 - 3:01PM
Celldex Therapeutics, Inc. (Nasdaq:CLDX) will release fourth
quarter and year-end 2015 financial results on Thursday, February
25, 2016 before the U.S. financial markets open. Celldex executives
will host a conference call at 8:00 a.m. EST on the same day to
discuss 2015 financial and business results and to provide an
update on key 2016 objectives.
The conference call and presentation will be webcast live over
the Internet and can be accessed by going to the "Events &
Presentations" page under the "Investors & Media" section of
the Celldex Therapeutics website at www.celldex.com. The call can
also be accessed by dialing (866) 743-9666 (within the United
States) or (760) 298-5103 (outside the United States). The passcode
is 50465153.
A replay of the call will be available approximately two hours
after the live call concludes through March 3, 2016. To access the
replay, dial (855) 859-2056 (within the United States) or (404)
537-3406 (outside the United States). The passcode is 50465153. The
webcast will also be archived on the Company's website.
About Celldex Therapeutics, Inc.Celldex is
developing targeted therapeutics to address devastating diseases
for which available treatments are inadequate. Our pipeline is
built from a proprietary portfolio of antibodies and
immunomodulators used alone and in strategic combinations to create
novel, disease-specific therapies that induce, enhance or suppress
the body's immune response. Visit www.celldex.com.
Contact
Sarah Cavanaugh
Vice President of Investor Relations & Corp Communications
Celldex Therapeutics, Inc.
(781) 433-3161
scavanaugh@celldex.com
Charles Liles
Manager of Investor Relations & Corp Communications
Celldex Therapeutics, Inc.
(781) 433-3107
cliles@celldex.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Sep 2023 to Sep 2024